Alnylam Pharmaceuticals, Inc. Savings & Investment Plan is a defined contribution plan with a 401k feature. This plan has a BrightScope Rating of 83. This plan is in the top 15% of plans for Account Balances and Salary Deferral. Alnylam Pharmaceuticals, Inc. Savings & Investment Plan currently has over 200 active participants and over $22.8M in plan assets.
|1.||Alnylam Pharmaceuticals, Inc. Common Stock||33%|
|2.||Fidelity Advisor New Insights||7%|
300 Third Street
Cambridge, MA 02142
|Industry||Professional, Scientific, and Technical Services|
|Net Plan Assets||$22,800,000|
|Avg Account Balance||$110,000|
|Ludwig Institute For Cancer...||85.1|
|International Association of...||79.2|
|Auditor||McGladrey Wealth Management LLC|
Information is provided 'as is' and solely for informational purposes, not for investment purposes or advice.
BrightScope is not a fiduciary under ERISA. BrightScope is not endorsed by or affiliated with FINRA.